BlackRock launches iShares US biotech ETF
TER of 0.35%
BlackRock launches US biotech ETF
BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.
Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using...
More on ETFs
Amundi unveils nine-strong ETF range with Solactive
Pure-beta offerings
Invesco partners with Elwood AM for blockchain ETF launch
Ongoing charge of 0.65%
Tabula launches short European high yield ETF
TER of 0.50%
SSGA to launch MSCI World ETF
TER of 0.12%
More news
Why gold is playing an increasingly important role in portfolios
The US dollar is close to peaking and the risks now seem to be on the downside.
Market Movers blog: Sterling up as Brexit delay agreed but still close to one-month low
Latest news and analysis
Five main GAM shareholders suffer losses of $840m
Fallout from Haywood suspension
Hipgnosis Songs fund acquires three 'genius-level' music catalogues
Songs from writers Johntá Austin, Sean Garrett and Rico Love
ASI and Gresham House form JV to roll out small-cap 'MiFID' fund
Strategic public equity
Back to Top